| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |